Water extracts of Aralia elata root bark enhances migration and matrix metalloproteinases secretion in porcine coronary artery endothelial cells

Biotechnology and Bioprocess Engineering

Volumn 10, Issue 4, 2005, Pages 372-377

  Oh, In Suk ^a   Han, Ji Won ^a   Kim, Hwan Gyu ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Aralia elata; FGF 2; Migration; MMPs

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARALIA ELATA EXTRACT; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER;

ANGIOGENESIS; ANIMAL CELL; ARALIA; ARTERY ENDOTHELIUM; ARTICLE; CAPILLARY; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME RELEASE; NONHUMAN; PLANT ROOT; SIGNAL TRANSDUCTION; SWINE; VEGETABLE;

ARALIA; ARALIA ELATA; SUIDAE;

EID: 24344499714     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931858     Document Type: Article

References (33)

1. Chung, C. K. and M. E. Jung (2003) Ethanol fraction of Aralia elata Seemann enhances antioxidant activity and lowers serum lipids in rats when administered with benzo(a)pyrene. Biol. Pharm. Bull. 26: 1502-1504.
2. Lee, E. B., O. J. Kim, S. S. Kang, and C. Jeong (2005) Araloside A, an antiulcer constituent from the root bark of Aralia elata. Biol. Pharm. Bull. 28: 523-526.
3. Song, S. J., N. Nakamura, C. M. Ma, M. Hatttori, and S. X. Xu (2001) Five saponins from the root bark of Aralia elata. Phytochemistry 56: 491-497.
4. Yoshikawa, M., T. Murakami, E. Harada, N. Murakami, J. Yamahara, and H. Matsuda (1996) Bioactive saponins and glycosides. VII. On the hypoglycemic principles from the root cortex of Aralia elata seem: Structure related hypoglycemic activity of oleanolic acid oligoglycoside. Chem. Pharm. Bull. 44: 1923-1927.
5. Hernandez, D. E., J. L. Hancke, and G. Wikman (1988) Evaluation of the anti-ulcer and antisecretory activity of extracts of Aralia elata root and Schizandra chinensis fruit in the rat. J. Ethnopharmacol. 23: 109-114.
6. Basilico, C. and D. Moscatelli (1992) The FGF family of growth factors and angiogenesis. Adv. Cancer Res. 59: 115-165.
7. Szebenyi, G. and J. F. Fallon (1999) Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185: 45-106.
8. Klein, S., F. G. Giancotti, M. Presta, S. M. Albelda, C. A. Buck, and D. B. Rifkin (1993) Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell 4: 973-982.
9. Mignatti, P. and D. B. Rifkin (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195.
10. Bikfalvi, A., S. Klein, G. Pintucci, and D. B. Rifkin (1997) Biological roles of fibroblast growth factor-2. Endocr. Rev. 18: 26-45.
11. Brooks, P. C., R. A. Clark, and D. A. Cheresh (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571.
12. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
13. Folkman, J. and Y. Shing (1992) Angiogenesis. J. Biol. Chem. 267: 10931-10934.
14. Brooks, P. C., S. Silletti, T. L. von Schalscha, M. Friedlander, and D. A. Cheresh (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92: 391-400.
15. Frederick, J. and J. F. Woessner Jr. (1988) The matrix metalloproteinase family. pp. 1-14. In: W. C. Parks and R. P. Mecham (eds.). Matrix Metalloproteinases. Academic Press, London, UK.
16. Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J. Clin. Invest. 103: 1237-1241.
17. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160.
18. Ferrara, N. and K. Alitalo (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5: 1359-1364.
19. Lee, J. B., J. S. Bae, J. H. Choi, J. H. Ham, Y. K. Min, H. M. Yang, T. Othman, and K. Shimizu (2004) Anticancer efficacies of doxorubicin, verapamil and quercetin on FM3A cells under hyperthermic temperature. Biotechnol. Bioprocess Eng. 9: 261-266.
20. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389-395.
21. Kim, I., S. O. Moon, K. N. Koh, H. Kim, C. S. Uhm, H. J. Kwak, N. G. Kim, and G. Y. Koh (1999) Molecular cloning, expression, and characterization of angiopoietin-related protein induces endothelial cell sprouting. J. Biol. Chem. 274: 26523-26528.
22. Haris, S. G. and M. L. Shuler (2003) Growth of endothelial cells on microfabricated silicon nitride membranes for an in vivo model of the blood-brain barrier. Biotechnol. Bioprocess Eng. 8: 246-251.
23. Oh, I. S. and H. G. Kim (2004) Vascular endothelial growth factor upregulates follistatin in human umbilical vein endothelial cells. Biotechnol. Bioprocess Eng. 9: 201-206.
24. Lee, Y., H. Kim, H. S. Choi, B. H. Kang, Y. B. Han, and S. J. Kim (2000) Water extract of 1:1 mixture of Phellodendron cortex and Aralia cortex has inhibitory effects on oxidative stress in kidney of diabetic rats. J. Ethnopharmacol. 73: 429-436.
25. Choi, D. B., W. S. Cha, S. H. Kang, and B. R. Lee (2004) Effect of Pleurotus ferulae extracts on viability of human lung cancer and cervical cancer cell lines. Biotechnol. Bioprocess Eng. 9: 356-361.
26. Rosen, E. M., L. Meromsky, E. Setter, D. W. Vinter, and I. D. Goldberg (1990) Quantitation of cytokine-stimulated migration of endothelium and epithelium by a new assay using microcarrier beads. Exp. Cell Res. 186: 22-31.
27. Kleiner, D. E., I. M. K. Margulis, and W. G. Stetler-Stevenson (1998) Proteinase assay/zymography. pp. 5A7.1-5A7.8. In: A. Doyle, J. B. Griffiths, and D. G. Newell (eds.). Cell and Tissue Culture: Laboratory Procedures. John Wiley and Sons, Sussex, UK.
28. Pepper, J. S., R. Montesano, S. J. Mandriota, L. Orci, and J. D. Vassalli (1996) Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49: 138-162.
29. Hiraoka, N., E. Allen, I. J. Apel, M. R. Gyetko, and S. J. Weiss (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365-377.
30. Brown, M. D. and O. Hudlicka (2003) Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6: 1-14.
31. DeClerck, Y. A., Y. D. Yean, H. S. Lu, J. Ting, and K. E. Langley (1991) Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 266: 3893-3899.
32. Ward, R. V., R. M. Hembry, J. J. Reynolds, and G. Murphy (1991) The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem. J. 278: 179-187.
33. Nagase, H. and J. F. Woessner Jr. (1999) Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494.